| Literature DB >> 31693861 |
Anupama Modi1, Shailender Dwivedi1, Dipayan Roy1, Manoj Khokhar1, Purvi Purohit1, Jeewanram Vishnoi2, Puneet Pareek3, Shailja Sharma1, Praveen Sharma1, Sanjeev Misra2.
Abstract
Growth differentiation factor-15 (GDF-15) is a novel cytokine secreted by a variety of cells like macrophages, adipocytes, normally expressed in high amounts by placenta. It is also highly expressed in multiple carcinomas like Colon, Breast, Pancreas, Liver, and Ovarian. Several reports on serum GDF-15 as a potential biomarker for diagnosis and prognosis of cancer are hampered by the lack of robust data, with large sample size and critical patient recruitment. However, experimental accounts on cancer tumors, cell lines, and animal models suggest GDF-15's role in cancer progression via endothelial mesenchymal transition, angiogenesis, metastasis, drug resistance and even stemness of various cancers. GDF-15 could be the point of amalgamation for the various hallmarks of cancer and can prove a useful therapeutic target in cancer. The current review was conceptualized with a thought of critically appraising the existing information of GDF-15 in carcinogenesis.Entities:
Keywords: Growth differentiation factor-15; angiogenesis; drug resistance; endothelial mesenchymal transition; metastases; radio-resistance; stemness
Mesh:
Substances:
Year: 2019 PMID: 31693861 DOI: 10.1080/08977194.2019.1685988
Source DB: PubMed Journal: Growth Factors ISSN: 0897-7194 Impact factor: 2.511